Briacell Therapeutics Corp
Philadelphia, PA
- UEI
- S4APLQN63FL6
- CAGE
- 9BWE9
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- United States, Pennsylvania, Philadelphia, Arch St, 3rd邮政编码: 19104
- Website
- briacell.com
- Founded
- 2004
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
SBA capabilities narrative
We are an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer. We are a clinical stage immunotherapy company developing treatments that destroy cancerous tumors by boosting the body's own cancer fighting cells.
Quick answers
Is Briacell Therapeutics Corp registered in SAM.gov?
Yes. Briacell Therapeutics Corp's SAM.gov registration is active through June 18, 2027.
What is Briacell Therapeutics Corp's most recent federal award?
Briacell Therapeutics Corp's most recent federal grant award is An off-the-shelf tumor cell vaccine with HLA-matching alleles for personalized treatment of advanced metastatic… (R44CA281555), from National Cancer Institute (NIH), on September 1, 2023.
On GovTribe
See Briacell Therapeutics Corp's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors